To develop a machine learning-based predictive model for local recurrence after radiotherapy in patients with gliomas, with interpretability enhanced through SHapley Additive exPlanations (SHAP). We retrospectively enrolled 145 patients with pathologically confirmed gliomas who underwent brain radiotherapy (training: validation = 102:43). Physiological and structural magnetic resonance imaging (MRI) were used to define habitat regions. A total of 2153 radiomic features were extracted from each MRI sequence in each habitat region, respectively. Relief and Recursive Feature Elimination were used for radiomic feature selection. Support vector machine (SVM) and random forest models incorporating clinical and radiomic features were constructed for each habitat region. The SHAP method was used to explain the predictive model. In the training cohort and validation cohort, the Physiological_Habitat1 (e-THRIVE)_radiomic SVM model demonstrated the best AUC of 0.703 (95% CI 0.569-0.836) and 0.670 (95% CI 0.623-0.717) compared to the other radiomic models. The SHAP summary plot and SHAP force plot were used to interpret the best-performing Physiological_Habitat1 (e-THRIVE)_radiomic SVM model. Radiomic features derived from the Physiological_Habitat1 (e-THRIVE) were predictive of local recurrence in glioma patients following radiotherapy. The SHAP method provided insights into how the tumor microenvironment might influence the effectiveness of radiotherapy in postoperative gliomas.

To construct and validate the optimal model for preoperative prediction of proliferative HCC based on habitat-derived radiomics features of Gd-EOB-DTPA-Enhanced MRI. A total of 187 patients who underwent Gd-EOB-DTPA-enhanced MRI before curative partial hepatectomy were divided into training (n=130, 50 proliferative and 80 nonproliferative HCC) and validation cohort (n=57, 25 proliferative and 32 nonproliferative HCC). Habitat subregion generation was performed using the Gaussian Mixture Model (GMM) clustering method to cluster all pixels to identify similar subregions within the tumor. Radiomic features were extracted from each tumor subregion in the arterial phase (AP) and hepatobiliary phase (HBP). Independent sample t tests, Pearson correlation coefficient, and Least Absolute Shrinkage and Selection Operator (LASSO) algorithm were performed to select the optimal features of subregions. After feature integration and selection, machine-learning classification models using the sci-kit-learn library were constructed. Receiver Operating Characteristic (ROC) curves and the DeLong test were performed to compare the identified performance for predicting proliferative HCC among these models. The optimal number of clusters was determined to be 3 based on the Silhouette coefficient. 20, 12, and 23 features were retained from the AP, HBP, and the combined AP and HBP habitat (subregions 1, 2, 3) radiomics features. Three models were constructed with these selected features in AP, HBP, and the combined AP and HBP habitat radiomics features. The ROC analysis and DeLong test show that the Naive Bayes model of AP and HBP habitat radiomics (AP-HBP-Hab-Rad) archived the best performance. Finally, the combined model using the Light Gradient Boosting Machine (LightGBM) algorithm, incorporating the AP-HBP-Hab-Rad, age, and AFP (Alpha-Fetoprotein), was identified as the optimal model for predicting proliferative HCC. For the training and validation cohort, the accuracy, sensitivity, specificity, and AUC were 0.923, 0.880, 0.950, 0.966 (95% CI: 0.937-0.994) and 0.825, 0.680, 0.937, 0.877 (95% CI: 0.786-0.969), respectively. In its validation cohort of the combined model, the AUC value was statistically higher than the other models (P<0.01). A combined model, including AP-HBP-Hab-Rad, serum AFP, and age using the LightGBM algorithm, can satisfactorily predict proliferative HCC preoperatively.

The processing of medical images plays a central role in modern diagnostics and therapy. Automated processing and analysis of medical images can efficiently accelerate clinical workflows and open new opportunities for improved patient care. However, the high variability, complexity, and varying quality of medical image data pose significant challenges. In recent years, the greatest progress in medical image analysis has been achieved through artificial intelligence (AI), particularly by using deep neural networks in the context of deep learning. These methods are successfully applied in medical image analysis, including segmentation, registration, and image synthesis.AI-based segmentation allows for the precise delineation of organs, tissues, or pathological changes. The application of AI-based image registration supports the accelerated creation of 3D planning models for complex surgeries by aligning relevant anatomical structures from different imaging modalities (e.g., CT, MRI, and PET) or time points. Generative AI methods can be used to generate additional image data for the improved training of AI models, thereby expanding the potential applications of deep learning methods in medicine. Examples from radiology, ophthalmology, dermatology, and surgery are described to illustrate their practical relevance and the potential of AI in image-based diagnostics and therapy.

Functional magnetic resonance imaging (fMRI) is a powerful tool for non-invasive evaluation of micro-changes in the kidneys. This study aims to develop classification and prognostic models based on multi-modal data. A total of 172 participants were included, and high-resolution multi-parameter fMRI technology was employed to obtain T2-weighted imaging (T2WI), blood oxygen level dependent (BOLD), and diffusion tensor imaging (DTI) sequence images. Based on clinical indicators, fMRI markers, serum and urine biomarkers (CD300LF, CST4, MMRN2, SERPINA1, l-glutamic acid dimethyl ester and phosphatidylcholine), machine learning algorithms were applied to establish and validate classification diagnosis models (Models 1-6) and risk-prognostic models (Models A-E). Additionally, accuracy, sensitivity, specificity, precision, area under the curve (AUC) and recall were used to evaluate the predictive performance of the models. A total of six classification models were established. Model 5 (fMRI + clinical indicators) exhibited superior performance, with an accuracy of 0.833 (95% confidence interval [CI]: 0.653-0.944). Notably, the multi-modal model incorporating image, serum and urine multi-omics and clinical indicators (Model 6) demonstrated higher predictive performance, achieving an accuracy of 0.923 (95% CI: 0.749-0.991). Furthermore, a total of five prognostic models at 2-year and 3-year follow-up were established. The Model E exhibited superior performance, achieving AUC values of 0.975 at the 2-year follow-up and 0.932 at the 3-year follow-up. Furthermore, Model E can identify patients with a high-risk prognosis. In clinical practice, the multi-modal models presented in this study demonstrate potential to enhance clinical decision-making capabilities regarding patient classification and prognosis prediction.

This meta-analysis systematically evaluated the diagnostic performance of artificial intelligence (AI) based on contrast-enhanced computed tomography (CECT) in detecting pancreatic ductal adenocarcinoma (PDAC). Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Diagnostic Test Accuracy (PRISMA-DTA) guidelines, a comprehensive literature search was conducted across PubMed, Embase, and Web of Science from inception to March 2025. Bivariate random-effects models pooled sensitivity, specificity, and area under the curve (AUC). Heterogeneity was quantified via I² statistics, with subgroup analyses examining sources of variability, including AI methodologies, model architectures, sample sizes, geographic distributions, control groups and tumor stages. Nineteen studies involving 5,986 patients in internal validation cohorts and 2,069 patients in external validation cohorts were included. AI models demonstrated robust diagnostic accuracy in internal validation, with pooled sensitivity of 0.94 (95% CI 0.89-0.96), specificity of 0.93 (95% CI 0.90-0.96), and AUC of 0.98 (95% CI 0.96-0.99). External validation revealed moderately reduced sensitivity (0.84; 95% CI 0.78-0.89) and AUC (0.94; 95% CI 0.92-0.96), while specificity remained comparable (0.93; 95% CI 0.87-0.96). Substantial heterogeneity (I² > 85%) was observed, predominantly attributed to methodological variations in AI architectures and disparities in cohort sizes. AI demonstrates excellent diagnostic performance for PDAC on CECT, achieving high sensitivity and specificity across validation scenarios. However, its efficacy varies significantly with clinical context and tumor stage. Therefore, prospective multicenter trials that utilize standardized protocols and diverse cohorts, including early-stage tumors and complex benign conditions, are essential to validate the clinical utility of AI.

<b>Background:</b> Chest radiographs play a crucial role in tuberculosis screening in high-prevalence regions, although widespread radiographic screening requires expertise that may be unavailable in settings with limited medical resources. <b>Objectives:</b> To evaluate a multimodal generative artificial intelligence (AI) model for detecting tuberculosis-associated abnormalities on chest radiography in patients undergoing tuberculosis screening. <b>Methods:</b> This retrospective study evaluated 800 chest radiographs obtained from two public datasets originating from tuberculosis screening programs. A generative AI model was used to create free-text reports for the radiographs. AI-generated reports were classified in terms of presence versus absence and laterality of tuberculosis-related abnormalities. Two radiologists independently reviewed the radiographs for tuberculosis presence and laterality in separate sessions, without and with use of AI-generated reports and recorded if they would accept the report without modification. Two additional radiologists reviewed radiographs and clinical readings from the datasets to determine the reference standard. <b>Results:</b> By the reference standard, 422/800 radiographs were positive for tuberculosis-related abnormalities. For detection of tuberculosis-related abnormalities, sensitivity, specificity, and accuracy were 95.2%, 86.7%, and 90.8% for AI-generated reports; 93.1%, 93.6%, and 93.4% for reader 1 without AI-generated reports; 93.1%, 95.0%, and 94.1% for reader 1 with AI-generated reports; 95.8%, 87.2%, and 91.3% for reader 2 without AI-generated reports; and 95.8%, 91.5%, and 93.5% for reader 2 with AI-generated reports. Accuracy was significantly lower for AI-generated reports than for both readers alone (p<.001), but significantly higher with than without AI-generated reports for one reader (reader 1: p=.47; reader 2: p=.47). Localization performance was significantly lower (p<.001) for AI-generated reports (63.3%) than for reader 1 (79.9%) and reader 2 (77.9%) without AI-generated reports and did not significantly change for either reader with AI-generated reports (reader 1: 78.7%, p=.71; reader 2: 81.5%, p=.23). Among normal and abnormal radiographs, reader 1 accepted 91.7% and 52.4%, while reader 2 accepted 83.2% and 37.0%, respectively, of AI-generated reports. <b>Conclusion:</b> While AI-generated reports may augment radiologists' diagnostic assessments, the current model requires human oversight given inferior standalone performance. <b>Clinical Impact:</b> The generative AI model could have potential application to aid tuberculosis screening programs in medically underserved regions, although technical improvements remain required.

The integration of artificial intelligence (AI) in cancer research has significantly advanced radiology, pathology, and multimodal approaches, offering unprecedented capabilities in image analysis, diagnosis, and treatment planning. AI techniques provide standardized assistance to clinicians, in which many diagnostic and predictive tasks are manually conducted, causing low reproducibility. These AI methods can additionally provide explainability to help clinicians make the best decisions for patient care. This review explores state-of-the-art AI methods, focusing on their application in image classification, image segmentation, multiple instance learning, generative models, and self-supervised learning. In radiology, AI enhances tumor detection, diagnosis, and treatment planning through advanced imaging modalities and real-time applications. In pathology, AI-driven image analysis improves cancer detection, biomarker discovery, and diagnostic consistency. Multimodal AI approaches can integrate data from radiology, pathology, and genomics to provide comprehensive diagnostic insights. Emerging trends, challenges, and future directions in AI-driven cancer research are discussed, emphasizing the transformative potential of these technologies in improving patient outcomes and advancing cancer care. This article is part of a special series: Driving Cancer Discoveries with Computational Research, Data Science, and Machine Learning/AI.

The study aimed to develop an AI-assisted ultrasound model for early liver trauma identification, using data from Bama miniature pigs and patients in Beijing, China. A deep learning model was created and fine-tuned with animal and clinical data, achieving high accuracy metrics. In internal tests, the model outperformed both Junior and Senior sonographers. External tests showed the model's effectiveness, with a Dice Similarity Coefficient of 0.74, True Positive Rate of 0.80, Positive Predictive Value of 0.74, and 95% Hausdorff distance of 14.84. The model's performance was comparable to Junior sonographers and slightly lower than Senior sonographers. This AI model shows promise for liver injury detection, offering a valuable tool with diagnostic capabilities similar to those of less experienced human operators.